RxDoctor Payments Data

Jennifer Oliver, DO

Interventional Pain Medicine · Winston Salem, NCNPI 1942599253

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,441 of the $1,642 with a category attached, or 87.7%. 9 manufacturers reported payments, led by Relievant Medsystems, Inc. at 29.8% of the total. Reporting peaked in 2023 at $833 and has fallen 81.3% since, to $156 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in NC, where the typical reported total is $2,787.

$1,642in general payments, 2019–2025

Across 30 payments — averaging $54.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Relievant Medsystems, Inc.$490
  • Medtronic$271
  • Nevro Corp.$248
  • Globus Medical$156
  • Saluda Medical Americas, Inc.$155
  • Boston Scientific$117
  • plus $205 from 3 others

What the payments were for

  • Travel & lodging$20212%
  • Food & beverage$1,44188%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,642 in reported general payments places this provider in the 25th percentile of 45 interventional pain medicine providers in North Carolina.

See all interventional pain medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$52,452
Medicare patients
182
Services billed
604

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine60$12,782
BelbucaBuprenorphine Hcl11$7,708
Pregabalin123$3,799
Duloxetine Hcl171$3,141
Celecoxib42$1,339
Gabapentin58$930
Tramadol Hcl54$508
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen23$492
Methocarbamol19$220
Cyclobenzaprine Hcl36$218
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$203
Tizanidine Hcl18$192
Baclofen11$77
Meloxicam16$16

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →